Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Rutgers, The State University of New Jersey · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
colon-cancerrectal-cancer
colon cancer, rectal cancer, sequential combined tas-102, oxaliplatin, irinotecan, late-line metastatic colorectal cancer, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1032413
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.